New Blood Test to Detect Latex Allergy
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




New Blood Test to Detect Latex Allergy

KALAMAZOO, Mich., Feb. 24, 1997 -- The U.S. Food and Drug Administration has granted clearance to market a new laboratory blood test for latex allergy. The simple serum test can identify immunoglobulin E antibodies (IgE) specific to latex allergies.

Using Pharmacia & Upjohn Diagnostics Division’s ImmunoCap Technology, this new laboratory blood test, which can be ordered through most major reference laboratories, can determine within a few hours whether a patient is hypersensitive to latex. Latex allergy, which affects approximately three million people nationwide, has emerged in recent years as a growing medical concern within the health care profession.

"The availability of a blood test provides physicians with a safe method to determine if their patients, especially those frequently exposed to latex products within a health care setting, are hypersensitive to latex products," said Dennis Ownby, M.D., Allergy Division, Henry Ford Hospital, Detroit "Since latex allergies may increase in severity, it is important that individuals at risk for developing a latex allergy seek testing through their health care provider before a potentially serious reaction can occur."

Latex allergies are classified as either a Type I or Type IV reaction, which can cause skin, respiratory and systemic responses. The most common reaction, a Type IV, usually includes a mild-to-moderate skin rash. A less common, yet more severe reaction is a Type I, which can lead to anaphylactic shock and in some cases death. There is no way to desensitize a sufferer to latex and avoidance can be challenging, since hundreds of everyday items contain latex, including disposable diapers, baby bottle nipples, balloons, surgical gloves and condoms.

According to the American Academy of Allergy, Asthma & Immunology (AAAAI), four groups of people are at risk for latex allergy: health care workers; latex industry workers; children with spina bifida; and persons with positive risk factors (e.g., multiple surgeries, recurrent contact with latex). The AAAAI recommends testing of individuals in these groups before exposure to latex.

The k82 ImmunoCap, when combined with the patient's serum, measures the level of immunoglobulin E antibodies (IgE) to latex-specific proteins. A patient who tests positive for the IgE antibody is determined to be latex sensitive.


E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities